Literature DB >> 19667758

Distinct subcellular distribution of cyclin dependent kinase 6.

Dawn M Kohrt1, Jennifer I Crary, Vasilena Gocheva, Philip W Hinds, Martha J Grossel.   

Abstract

Several studies have recently reported that the cyclin dependent kinase (cdk) 6 oncogene plays a role in differentiation of a variety of cell types. This novel function expands the previously understood function of cdk6 as a regulator of G(1) phase of the cell cycle. The proposed mechanisms of these functions both require nuclear localization. That is, cdk6 phosphorylation of the retinoblastoma protein (pRb) to regulate cell cycle, and the recently proposed transcriptional regulation to block differentiation, are both nuclear functions that predict nuclear localization of the kinase. This report provides a thorough analysis of cdk6 localization and compares the localization of a commonly used mutant cdk6 to the corrected wildtype sequence as recorded in GenBank. The widely shared mutant of cdk6 contains a tyrosine residue at amino acid 224 (instead of an aspartic acid) introducing a potential phosphorylation site to the cdk6 sequence. Results indicate a majority of cdk6 is localized to the cytoplasm with concentrations of cdk6 in the edges of the cytoplasm and in the cytoplasmic extensions of cells. The results of this study may help to better understand the emerging roles of cdk6 in cell cycle control, differentiation and cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19667758      PMCID: PMC2774137          DOI: 10.4161/cc.8.17.9521

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  26 in total

1.  Core transcriptional regulatory circuitry in human embryonic stem cells.

Authors:  Laurie A Boyer; Tong Ihn Lee; Megan F Cole; Sarah E Johnstone; Stuart S Levine; Jacob P Zucker; Matthew G Guenther; Roshan M Kumar; Heather L Murray; Richard G Jenner; David K Gifford; Douglas A Melton; Rudolf Jaenisch; Richard A Young
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

Review 2.  From cell cycle to differentiation: an expanding role for cdk6.

Authors:  Martha J Grossel; Philip W Hinds
Journal:  Cell Cycle       Date:  2006-02-06       Impact factor: 4.534

3.  The p16(INK4a) tumour suppressor protein inhibits alphavbeta3 integrin-mediated cell spreading on vitronectin by blocking PKC-dependent localization of alphavbeta3 to focal contacts.

Authors:  R Fåhraeus; D P Lane
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

4.  Changes in motility, gene expression and actin dynamics: Cdk6-induced cytoskeletal changes associated with differentiation in mouse astrocytes.

Authors:  Peter Slomiany; Thomas Baker; Emily R Elliott; Martha J Grossel
Journal:  J Cell Biochem       Date:  2006-10-01       Impact factor: 4.429

5.  Cdk6 blocks myeloid differentiation by interfering with Runx1 DNA binding and Runx1-C/EBPalpha interaction.

Authors:  T Fujimoto; K Anderson; S E W Jacobsen; S-I Nishikawa; C Nerlov
Journal:  EMBO J       Date:  2007-04-12       Impact factor: 11.598

6.  Genetic unmasking of an epigenetically silenced microRNA in human cancer cells.

Authors:  Amaia Lujambio; Santiago Ropero; Esteban Ballestar; Mario F Fraga; Celia Cerrato; Fernando Setién; Sara Casado; Ana Suarez-Gauthier; Montserrat Sanchez-Cespedes; Anna Git; Anna Gitt; Inmaculada Spiteri; Partha P Das; Carlos Caldas; Eric Miska; Manel Esteller
Journal:  Cancer Res       Date:  2007-02-15       Impact factor: 12.701

7.  cdk6 can shorten G(1) phase dependent upon the N-terminal INK4 interaction domain.

Authors:  M J Grossel; G L Baker; P W Hinds
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

8.  Modeling mutations in the G1 arrest pathway in human gliomas: overexpression of CDK4 but not loss of INK4a-ARF induces hyperploidy in cultured mouse astrocytes.

Authors:  E C Holland; W P Hively; V Gallo; H E Varmus
Journal:  Genes Dev       Date:  1998-12-01       Impact factor: 11.361

9.  The let-7 microRNA represses cell proliferation pathways in human cells.

Authors:  Charles D Johnson; Aurora Esquela-Kerscher; Giovanni Stefani; Mike Byrom; Kevin Kelnar; Dmitriy Ovcharenko; Mike Wilson; Xiaowei Wang; Jeffrey Shelton; Jaclyn Shingara; Lena Chin; David Brown; Frank J Slack
Journal:  Cancer Res       Date:  2007-08-15       Impact factor: 12.701

10.  miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.

Authors:  Joachim Silber; Daniel A Lim; Claudia Petritsch; Anders I Persson; Alika K Maunakea; Mamie Yu; Scott R Vandenberg; David G Ginzinger; C David James; Joseph F Costello; Gabriele Bergers; William A Weiss; Arturo Alvarez-Buylla; J Graeme Hodgson
Journal:  BMC Med       Date:  2008-06-24       Impact factor: 8.775

View more
  11 in total

Review 1.  Targeting CDK6 in cancer: State of the art and new insights.

Authors:  Solomon Tadesse; Mingfeng Yu; Malika Kumarasiri; Bich Thuy Le; Shudong Wang
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  Expression of CDK6 in Oral Squamous Cell Carcinomas

Authors:  Azadeh Andisheh-Tadbir; Mohammad Javad Ashraf; Naghmeh Jeiroodi
Journal:  Asian Pac J Cancer Prev       Date:  2018-04-25

Review 3.  Molecular and cellular basis of autosomal recessive primary microcephaly.

Authors:  Marine Barbelanne; William Y Tsang
Journal:  Biomed Res Int       Date:  2014-12-08       Impact factor: 3.411

4.  Integrative Phosphoproteomics Links IL-23R Signaling with Metabolic Adaptation in Lymphocytes.

Authors:  Corinne Lochmatter; Roman Fischer; Philip D Charles; Zhanru Yu; Fiona Powrie; Benedikt M Kessler
Journal:  Sci Rep       Date:  2016-04-15       Impact factor: 4.379

5.  Human genome-wide RNAi screen reveals host factors required for enterovirus 71 replication.

Authors:  Kan Xing Wu; Patchara Phuektes; Pankaj Kumar; Germaine Yen Lin Goh; Dimitri Moreau; Vincent Tak Kwong Chow; Frederic Bard; Justin Jang Hann Chu
Journal:  Nat Commun       Date:  2016-10-17       Impact factor: 14.919

6.  Regulation of miRNA-29c and its downstream pathways in preneoplastic progression of triple-negative breast cancer.

Authors:  Anjana Bhardwaj; Harpreet Singh; Kimal Rajapakshe; Kazunoshin Tachibana; Nivetha Ganesan; Yinghong Pan; Preethi H Gunaratne; Cristian Coarfa; Isabelle Bedrosian
Journal:  Oncotarget       Date:  2017-03-21

7.  Inactive Tlk associating with Tak1 increases p38 MAPK activity to prolong the G2 phase.

Authors:  Gwo-Jen Liaw; Chuen-Sheue Chiang
Journal:  Sci Rep       Date:  2019-02-13       Impact factor: 4.379

8.  Human pancreatic β-cell G1/S molecule cell cycle atlas.

Authors:  Nathalie M Fiaschi-Taesch; Jeffrey W Kleinberger; Fatimah G Salim; Ronnie Troxell; Rachel Wills; Mansoor Tanwir; Gabriella Casinelli; Amy E Cox; Karen K Takane; Donald K Scott; Andrew F Stewart
Journal:  Diabetes       Date:  2013-03-14       Impact factor: 9.461

9.  Chemical Composition and In Vitro Cytotoxicity of Essential Oils from Leaves and Flowers of Callistemon citrinus from Western Himalayas.

Authors:  Dharmesh Kumar; Mahesh Sukapaka; G D Kiran Babu; Yogendra Padwad
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

10.  CDK6 binds and promotes the degradation of the EYA2 protein.

Authors:  Dawn Kohrt; Jennifer Crary; Marc Zimmer; Aaron N Patrick; Heide L Ford; Philip W Hinds; Martha J Grossel
Journal:  Cell Cycle       Date:  2013-10-12       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.